The cell type markers included EPCAM, KRT19, KRT14, ERBB2, ESR1 for epithelial cells (Figure 1F), PECAM1, VWF for endothelial cells (Figure 1G), DCN, COL1A1, COL1A2, COL3A1, CFD, and PRGFRA for cancer-associated fibroblasts (CAFs) (Figure 1H), ACTA2, TAGLN, MCAM for perivascular cells (Figure 1I), CD79A, CD79B for B cells (Figure 1J), LYZ, IL1B, MSR1 for macrophages (Figure 1K), JCHAIN, MZB1 for plasma cells (Figure 1L), and CD3G, CD3D, IL7R, NKG7, GNLY, CD8A for T cells (Figure 1M). This evidence concerns the gene CD79B and cancer.